ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EMA clears use of COVID-19 Vaccine AstraZeneca europeanpharmaceuticalreview
March 22, 2021The EMA’s drug safety committee concluded that the vaccine is not associated with an increased risk of thromboembolic events and that its benefits still outweigh its risks.
Pharma Sources Insight January 2025
